Johrei

Founded in Japan by Mokichi Okada and brought to the US in the early 1950s, Johrei is classified as a biofield energy healing technique involving a non-touch transfer of life energy.

The Johrei practitioner is motivated by goodwill and visualizes that healing light enters his/her body and passes through the healer's hands to the recipient.

Practitioners develop their healing ability through a life of spiritual practice rather than through formal training. The Johrei practitioner is motivated by goodwill and visualizes that healing light enters his/her body and passes through the healer's hands to the recipient.

The Johrei Institute is an international nonprofit organization governed by Johrei fellowships in Japan and North America. The Johrei Fellowship in North America lists their locations in the US and Canada and provides information on how one can learn to practice Johrei.1

For a description and summary of research of Johrei’s use in cancer, see the Lutgendorf SK et al. chapter in Abrams & Weil's Integrative Oncology, 2nd Edition.

Clinical Practice Guidelines

2009 evidence-based clinical practice guidelines for integrative oncology conclude that therapies based on a philosophy of bioenergy fields are safe and may provide some benefit for reducing stress and enhancing quality of life. Only limited evidence is available regarding their efficacy for symptom management, including reducing pain and fatigue. The Society for Integrative Oncology gives a strong recommendation for these therapies:2

  • For reducing anxiety: grade 1B (strong recommendation, moderate-quality evidence)
  • For pain, fatigue, and other symptom management: grade 1C (strong recommendation, low- or very low-quality evidence)

Written by Laura Pole, RN, MSN, OCNS, and reviewed by Nancy Hepp, MS; most recent update on October 17, 2018. Note: BCCT has not conducted a review of evidence on Johrei. Information on this page comes from the Johrei Institute and other sources at noted.

View All References

More Information

Enter your comments or questions below.

Comments (0)




Allowed tags: <b><i><br>Add a new comment: